HALB
Halberd Corp

2,769
Mkt Cap
$825,400.00
Volume
220,100.00
52W High
$0.0043
52W Low
$0.0011
PE Ratio
0.00
HALB Fundamentals
Price
$0.0016
Prev Close
$0.0016
Open
$0.0015
50D MA
$0.0015
Beta
0.76
Avg. Volume
1.49M
EPS (Annual)
$0.00
P/B
-1.33
Halberd Corp. is a development stage company, which engages in the research and development of antibodies and devices for the prevention, detection, and treatment of neurodegenerative diseases. It offers patented extracorporeal treatment that is applicable to various blood-borne and neurologic diseases such as PTSD/ CTE (Post Traumatic Stress Disorder/Chronic Traumatic Encephalopathy), Alzheimer's Disease, and Parkinson's Disease. The company was founded by Mark Sven Lundquist and John Christopher Maddox on January 26, 2009 and is headquartered in Jackson Center, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Halberd Corp?
What is the 52-week high for Halberd Corp?
What is the 52-week low for Halberd Corp?
What is Halberd Corp stock price today?
What was Halberd Corp stock price yesterday?
What is the PE ratio of Halberd Corp?
What is the Price-to-Book ratio of Halberd Corp?
What is the 50-day moving average of Halberd Corp?

Latest HALB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.